Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01205880Phase 4Completed
Phase 4, randomised, single-blind trial of clobetasol and calcitriol in plaque psoriasis. Primary endpoint: Target Lesion Severity Score at 4 weeks. Started Dec 2009; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01205880.